Literature DB >> 7294371

Tissue redistribution of fentanyl and termination of its effects in rats.

C C Hug, M R Murphy.   

Abstract

The kinetics of fentanyl elimination from plasma suggest its rapid and extensive uptake by tissues. The authors determined the relationships between tissue and plasma concentrations of fentanyl. Six rats injected iv with 3H-fentanyl citrate (50 micrograms/kg) were sacrificed at each of the following times: 1.5, 5, 15, 30, 60, 120, and 240 min after injection. Tissues were analyzed for unchanged 3H-fentanyl citrate and for total 3H-radioactivity. Fentanyl effects were evident 10 s after injection; recovery began at 5 min and was complete within 60 min. Fentanyl concentrations in brain, heart, and lung equilibrated with that in plasma before 1.5 min and declined at the same rate (t 1/2 alpha = 8 min, t 1/2 beta = 45 min). Fentanyl uptake by muscle and fat was slower and equilibration with plasma occurred by 120 min. Muscle accumulated 56 per cent of the dose within 5 min by which time brain fentanyl levels had declined by 90 per cent. Only 6 per cent of the dose was in fat at 5 min but this increased to a maximum of 17 per cent at 30 min. Fentanyl was extensively metabolized; metabolites represented 25 per cent of body 3H-radioactivity at 15 min, and 80 per cent at 4 h. The authors conclude that the short duration of fentanyl effect is due to its rapid redistribution from sites of action in the brain to sites of storage (muscle and fat) and biotransformation (liver). The elimination of fentanyl from the body is governed by its reuptake from storage sites and its metabolism in the liver. Most of the dose is ultimately excreted in the form of fentanyl metabolites in urine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7294371     DOI: 10.1097/00000542-198110000-00006

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  28 in total

1.  Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.

Authors:  Mona Darwish; Mary Kirby; Philmore Robertson; Edward Hellriegel; John G Jiang
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers.

Authors:  Mona Darwish; Kenneth Tempero; Mary Kirby; Jeffrey Thompson
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats.

Authors:  Michael D Raleigh; Federico Baruffaldi; Samantha J Peterson; Morgan Le Naour; Theresa M Harmon; Jennifer R Vigliaturo; Paul R Pentel; Marco Pravetoni
Journal:  J Pharmacol Exp Ther       Date:  2018-11-08       Impact factor: 4.030

Review 4.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

5.  Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry.

Authors:  Michael G Feasel; Ariane Wohlfarth; John M Nilles; Shaokun Pang; Robert L Kristovich; Marilyn A Huestis
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

6.  Apnoea and unconsciousness after apparent recovery from alfentanil-supplemented anaesthesia.

Authors:  R J Hudson
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

Review 7.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

8.  Comparative evaluation of recovery characteristics of fentanyl and butorphanol when used as supplement to propofol anaesthesia.

Authors:  Vikramjeet Arora; Sukhmindar Jit Singh Bajwa; Sarajit Kaur
Journal:  Int J Appl Basic Med Res       Date:  2012-07

9.  Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study.

Authors:  Neha Parikh; Venkat Goskonda; Ashok Chavan; Larry Dillaha
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

10.  Fentanyl-oxygen versus fentanyl-N2O/oxygen anaesthesia in children undergoing cardiac surgery.

Authors:  P Crean; G Koren; G Goresky; J Klein; S Macleod
Journal:  Can Anaesth Soc J       Date:  1986-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.